Catch up on the top radiology content of the past week.
|Articles|March 3, 1999
Aydin Displays buys MegaScan
The MegaScan line of monitors formerly sold by EMED found a new home after monitor manufacturer Aydin Displays acquired the business from Access Radiology. The deal should help Aydin expand into the healthcare business from its core activities in
Advertisement
The MegaScan line of monitors formerly sold by EMED found a new home after monitor manufacturer Aydin Displays acquired the business from Access Radiology. The deal should help Aydin expand into the healthcare business from its core activities in military and industrial displays. Terms of the deal were not disclosed.
Teleradiology firm EMED provided MegaScan monitors to PACS OEMs, and Access of Lexington, MA, acquired the line with its purchase of EMED in December (SCAN 11/25/98). Access sold the division to Aydin as part of a larger strategy of focusing on electronic medical imaging technology and systems, according to Scott Sheldon, Access CEO.
Although Aydin Displays has primarily developed CRT monitor technology for military and industrial applications, the Horsham, PA-based company has begun developing active matrix liquid crystal display (AMLCD) flat-panel technology for medical uses. The MegaScan deal offers Aydin a line of high-resolution medical imaging CRT monitors and gives MegaScan financial stability, according to Aydin.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
Emerging Research Insights and New Advances in Neuroradiology
5